Prognostic utility of FDG PET/CT in advanced ovarian, fallopian and primary peritoneal high-grade serous cancer patients before and after neoadjuvant chemotherapy

被引：0
|
作者：
Masao Watanabe
Yuji Nakamoto
Takayoshi Ishimori
Tsuneo Saga
Aki Kido
Junzo Hamanishi
Yasuyo Hamanaka
Kaori Togashi
机构：
[1] Kyoto University,Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine
[2] Kyoto University,Department of Gynecology and Obstetrics, Graduate School of Medicine
[3] Takeda Oncologic Positron Imaging Center,undefined
来源：
Annals of Nuclear Medicine | 2020年 / 34卷
关键词：
18F-FDG; PET–CT; Ovary; Fallopian tube; Peritoneum;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：128 / 135
页数：7
相关论文
共 50 条
  • [21] Impact of neoadjuvant chemotherapy on HRD testing in patients with advanced high-grade epithelial ovarian cancer
    Betella, Ilaria
    Rappa, Alessandra
    Sala, Isabella
    Derio, Silvia
    Multinu, Francesco
    Ribero, Lucia
    Bruni, Simone
    De Vitis, Luigi
    Rosanu, Marina
    Ranghiero, Alberto
    Vacirca, Davide
    Adorisio, Riccardo
    Aletti, Giovanni
    Zanagnolo, Vanna
    Bagnardi, Vincenzo
    Barberis, Massimo
    Rocco, Elena Guerini
    Colombo, Nicoletta
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A200 - A201
  • [22] FDG PET/CT diagnostic and prognostic value before hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer with peritoneal carcinomatosis
    Zwarthoed, C.
    Bereder, J. -M.
    Viau, P.
    Grangeon, C.
    Maurel, F.
    Darcourt, J.
    Mounier, N.
    Razzouk-Cadet, M.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2014, 38 (06): : 398 - 407
  • [23] Improvement of radiological disease on CT after neoadjuvant chemotherapy may not correlate with chemotherapy response score (CRS) in advanced tubo-ovarian high-grade serous ovarian carcinoma
    Sugrue, R.
    James, K.
    Growdon, W. B.
    Clark, R. M.
    del Carmen, M. G.
    Melamed, A.
    Bregar, A. J.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 110 - 111
  • [24] PREDICTIVE AND PROGNOSTIC VALUE OF PREOPERATIVE INTRATUMORAL FDG UPTAKE HETEROGENEITY IN HIGH-GRADE SEROUS OVARIAN CANCER PATIENTS
    Zheng, F.
    Shuai, L.
    Hao, W.
    Xingzhu, J.
    Xiaojun, C.
    Wu, X.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 879 - 879
  • [25] Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
    Lee, Yong Jae
    Woo, Ha Young
    Kim, Yoo-Na
    Park, Junsik
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    Park, Eunhyang
    Joung, Je-Gun
    Lee, Jung-Yun
    CANCERS, 2022, 14 (09)
  • [26] Is there any metabolic parameter of staging 18F-FDG-PET/CT related to the therapeutic strategy performed (primary cytoreduction vs. neoadjuvant chemotherapy and interval cytoreduction) in patients with high-grade serous ovarian cancer?
    Sancho Rodriguez, L.
    Sanchez Lorenzo, L.
    Boria Alegre, F.
    Iscar Galan, T.
    Garcia Belaustegui, L.
    Carrasco Rubio, V.
    Beorlegui Arteta, C.
    Romera Caballo, M.
    Betech Anta, V.
    Garcia Velloso, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S711 - S711
  • [27] Acquired chemotherapy resistance in high-grade serous ovarian cancer patients.
    Christie, Elizabeth L.
    Beach, Jessica
    Etemadmoghadam, Dariush
    Garsed, Dale
    Patch, Ann-Marie
    Fereday, Sian
    Pattnaik, Swetansu
    Brady, Samuel
    Bild, Andrea
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 20 - 20
  • [28] Prognostic significance of supraclavicular lymphadenopathy in patients with high-grade serous ovarian cancer
    Cybulska, P.
    Spirtos, A.
    Filippova, O. T.
    Leitao, M. M., Jr.
    Sonoda, Y.
    Mueller, J. J.
    Gardner, G. J.
    Zivanovic, O.
    Hayes, S. A.
    Roche, K. Long
    Chi, D. S.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 281 - 282
  • [29] Prognostic significance of supraclavicular lymphadenopathy in patients with high-grade serous ovarian cancer
    Cybulska, Paulina
    Hayes, Sara A.
    Spirtos, Alexandra
    Rafizadeh, Michael J.
    Filippova, Olga T.
    Leitao, Mario
    Zivanovic, Oliver
    Sonoda, Yukio
    Mueller, Jennifer
    Lakhman, Yuliya
    Long, Kara
    Chi, Dennis S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (09) : 1377 - 1380
  • [30] Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma
    Xie, Meng
    Zhang, Xuyin
    Jia, Zhan
    Ren, Yunyun
    Wang, Wenping
    ONCOLOGY LETTERS, 2014, 8 (04) : 1652 - 1656
12345